Correction: Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancer.
J Exp Clin Cancer Res
; 42(1): 321, 2023 Nov 28.
Article
in En
| MEDLINE
| ID: mdl-38012784
Full text:
1
Collection:
01-internacional
Health context:
1_ASSA2030
/
2_ODS3
Database:
MEDLINE
Language:
En
Journal:
J Exp Clin Cancer Res
Year:
2023
Document type:
Article